Target intelligence / Profile preview

Ribosomal protein S20 pseudogene 22 (RPS20P22)

Target: RPS20P22
Molecular classification: Other (pseudogene; not a protein, not a receptor, enzyme, transporter, etc.)

Overview

Ribosomal protein S20 pseudogene 22 (RPS20P22) is a processed pseudogene in the human genome that corresponds to the coding gene for ribosomal protein S20. Pseudogenes like RPS20P22 do not encode functional proteins and typically arise from duplication or retrotransposition of functional genes. RPS20P22 does not participate in protein synthesis, cellular signaling, or direct disease processes and is not considered a therapeutic target or biomarker. Any biological functions or drug interactions relevant to ribosomal protein S20 are attributed to the protein-coding RPS20 gene, not this pseudogene[1][4][5][2]. If you are seeking information on a *therapeutic target*, you should search for the **RPS20 gene (Ribosomal protein S20)**, not the pseudogene RPS20P22[5][6][9][8].

Other names: RPS20P22Ribosomal protein S20 pseudogene 22

Mechanism of action

None (no known mechanism for drug interaction with a pseudogene)

Biological functions

None (as a pseudogene, it does not encode a product with biological function; the functional form is encoded by the RPS20 gene)

Disease associations

None known (The functional ribosomal protein S20, encoded by RPS20, is associated with ribosome function and related disease risks[5][6][9], but the pseudogene RPS20P22 is not implicated in disease)

Safety considerations

None (not a drug target; no safety information relevant)

Interacting drugs

None (No drugs interact with RPS20P22 pseudogene; drugs may target ribosomes more broadly, but not the pseudogene)

Biomarkers

None (no reports of RPS20P22 pseudogene as a biomarker; functional ribosomal proteins may in theory be used as biomarkers[6], but not the pseudogenes)

Beyond the preview

Go deeper on Ribosomal protein S20 pseudogene 22 (RPS20P22).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S20 pseudogene 22 (RPS20P22).

Explore the full profile